A Multi-Center, Randomized, Open-Label Evaluation of MENOPUR Versus FOLLISTIM in Polycystic Ovarian Syndrome (PCOS) Patients.

Trial Profile

A Multi-Center, Randomized, Open-Label Evaluation of MENOPUR Versus FOLLISTIM in Polycystic Ovarian Syndrome (PCOS) Patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Jan 2012

At a glance

  • Drugs Follitropin beta; Leuprorelin; Menotropin; Progesterone
  • Indications Female infertility
  • Focus Therapeutic Use
  • Sponsors Ferring Pharmaceuticals
  • Most Recent Events

    • 05 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 12 Aug 2010 Planned end date changed from 1 Jul 2010 to 1 Sep 2010 as reported by ClinicalTrials.gov.
    • 12 Aug 2010 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top